S

Syno Capital

10 employees

Syno Capital is a principal investment firm focused on life science and healthcare sector investments in New York.

Investor insights

Sectors invested in

Medical5

Biotechnology5

Health Care4

Pluripotent Stem Cells2

Molecular Biology2

DNA test2

iPSC2

Personalized Medicine2

DNA2

Personal Health2

Health and Wellness2

Regenerative Medicine2

Stem Cell Research2

Tissue Engineering2

Pharmaceutical2

DMD cardiomyopathy1

Elder Care1

In-home care1

Caregiving1

Home Health Care1

Funding rounds participated in

$30M sweet spot round size

Most of their 6 investments are in rounds between $20M and $45M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Private Equity

Financial Services

Health Care

Biotech

Healthcare

Life Science

Venture Capital

Date founded

2015

Investments made

P

PhaseBio Pharmaceuticals, Inc. raised $34M on September 5, 2018

Investors: Fletcher Spaght, Inc., Mountain Group Partners and Syno Capital

T

TCR² Therapeutics Inc. raised $125M on March 21, 2018

Investors: Redmile Group, Hillhouse Capital Management, UBS Asset Management, Mirae Asset MAPS Global Investments Co., Ltd, MPM Capital, Haitong International Securities Group Limited, Sirona Capital and Syno Capital

O

ORIG3N raised $20M on June 27, 2017

Investors: Spectrum Health Ventures, DEFTA Partners, Labcorp and Syno Capital

H

Honor raised $45M on August 5, 2016

Investors: Blue Ivy Ventures, Thrive Capital, 8VC and Syno Capital

O

ORIG3N raised $13M on December 12, 2015

Investors: DEFTA Partners, Mountain Group Partners, Labcorp and Syno Capital

L

LungLife AI raised $26M on June 17, 2015

Investors: Livzon, Greenwoods Asset Management and Syno Capital